LANXESS AG
Develops & markets specialty chemicals, additives, and consumer protection products for many industries.
LXS | F
Overview
Corporate Details
- ISIN(s):
- DE0005470405 (+1 more)
- LEI:
- 529900PTLRE72EMYIJ77
- Country:
- Germany
- Address:
- Kennedyplatz 1, 50569 Köln
- Website:
- https://lanxess.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
LANXESS AG is a specialty chemicals company whose core business is the development, manufacturing, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products. The company's portfolio serves a wide range of applications, including preservatives for food and personal care (e.g., Purox® B, Neolone® PH Max), active ingredients for insect repellents (Saltidin®), aroma chemicals, pigments, and high-performance plastics. Founded in 2004 as a spin-off from Bayer AG, LANXESS provides solutions for various industries, operating under the motto "Energizing Chemistry".
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-08 12:50 |
Regulatory News Service
|
English | 17.7 KB | ||
| 2025-09-24 18:31 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 18.9 KB | ||
| 2025-09-22 16:47 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 17.7 KB | ||
| 2025-09-16 10:54 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 17.7 KB | ||
| 2025-08-14 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 643.5 KB | ||
| 2025-07-04 16:41 |
Major Shareholding Notification
|
English | 65.6 KB | ||
| 2025-05-28 00:00 |
Post-Annual General Meeting Information
Ergänzung der Veröffentlichung vom 15.04.2025
|
German | 2.1 KB | ||
| 2025-05-08 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 399.4 KB | ||
| 2025-04-22 16:35 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 23.3 KB | ||
| 2025-04-15 00:00 |
Regulatory News Service
Ergänzt am 28.05.2025
|
German | 4.7 MB | ||
| 2025-04-10 15:05 |
Pre-Annual General Meeting Information
LANXESS Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung…
|
German | 100.3 KB | ||
| 2025-03-24 13:58 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.9 KB | ||
| 2025-03-21 12:18 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 17.4 KB | ||
| 2025-03-21 00:00 |
Annual Report
Annual financial report 2024
|
English | 5.7 MB | ||
| 2025-03-20 18:54 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 17.7 KB |
Automate Your Workflow. Get a real-time feed of all LANXESS AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for LANXESS AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-03-16 | Borkowsky, Dr. Anno | Board | Buy | None | 63,858.53 EUR |
| 2023-03-16 | Fink, Dr. Hubert | Board | Buy | None | 100,515.00 EUR |
| 2023-03-16 | Zachert, Matthias | Board | Buy | None | 200,550.40 EUR |
